UPDATE: Barclays Downgrades Prelude Therapeutics (PRLD) to Equalweight

Go back to UPDATE: Barclays Downgrades Prelude Therapeutics (PRLD) to Equalweight
(NASDAQ: PRLD) Delayed: 5.55 +0.19 (3.54%)
Previous Close $5.36    52 Week High
Open $5.45    52 Week Low
Day High $5.61    P/E N/A 
Day Low $5.15    EPS
Volume 452,124